Glickman Mark A - Insider Non-Derivative Transactions at NeuroBo Pharmaceuticals, Inc. (NRBO) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Jun 7, 2024, Glickman Mark A's relationship to NeuroBo Pharmaceuticals, Inc. (NRBO) is Director, and currently has 9,740 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NRBO insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Glickman Mark A - Insider Non-Derivative Transactions of NRBO Common Stock
Glickman Mark A - Insider Non-Derivative Transactions at NRBO
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 8, 2024 | Acquisition -- (Common Stock) | 5051 | 0 | 9740 |
| Jul 28, 2023 | Acquisition -- (Common Stock) | 25000 | 0 | 25000 |
| Jul 28, 2023 | Acquisition -- (Common Stock) | 12500 | 0 | 37500 |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.